α-Melanocyte-Stimulating Hormone and Related Tripeptides: Biochemistry, Antiinflammatory and Protective Effects in Vitro and in Vivo, and Future Perspectives for the Treatment of Immune-Mediated Inflammatory Diseases
Open Access
- 1 August 2008
- journal article
- review article
- Published by The Endocrine Society in Endocrine Reviews
- Vol. 29 (5), 581-602
- https://doi.org/10.1210/er.2007-0027
Abstract
α-MSH is a tridecapeptide derived from proopiomelanocortin. Many studies over the last few years have provided evidence that α-MSH has potent protective and antiinflammatory effects. These effects can be elicited via centrally expressed melanocortin receptors that orchestrate descending neurogenic antiinflammatory pathways. α-MSH can also exert antiinflammatory and protective effects on cells of the immune system and on peripheral nonimmune cell types expressing melanocortin receptors. At the molecular level, α-MSH affects various pathways implicated in regulation of inflammation and protection, i.e., nuclear factor-κB activation, expression of adhesion molecules and chemokine receptors, production of proinflammatory cytokines and mediators, IL-10 synthesis, T cell proliferation and activity, inflammatory cell migration, expression of antioxidative enzymes, and apoptosis. The antiinflammatory effects of α-MSH have been validated in animal models of experimentally induced fever; irritant and allergic contact dermatitis, vasculitis, and fibrosis; ocular, gastrointestinal, brain, and allergic airway inflammation; and arthritis, but also in models of organ injury. One obstacle limiting the use of α-MSH in inflammatory disorders is its pigmentary effect. Due to its preserved antiinflammatory effect but lack of pigmentary action, the C-terminal tripeptide of α-MSH, KPV, has been delineated as an alternative for antiinflammatory therapy. KdPT, a derivative of KPV corresponding to amino acids 193–195 of IL-1β, is also emerging as a tripeptide with antiinflammatory effects. The physiochemical properties and expected low costs of production render both agents suitable for the future treatment of immune-mediated inflammatory skin and bowel disease, fibrosis, allergic and inflammatory lung disease, ocular inflammation, and arthritis.Keywords
This publication has 179 references indexed in Scilit:
- PepT1-Mediated Tripeptide KPV Uptake Reduces Intestinal InflammationGastroenterology, 2008
- Neuroprotective effects of melanocortins in experimental spinal cord injury. An experimental study in the rat using topical application of compounds with varying affinity to melanocortin receptorsJournal of Neural Transmission, 2006
- Prostaglandin production by melanocytic cells and the effect of α‐melanocyte stimulating hormoneFEBS Letters, 2004
- α‐Melanocyte‐stimulating hormone induces cell death in mast cells: involvement of NF‐κBFEBS Letters, 2003
- α-melanocyte stimulating hormone suppresses intracerebral tumor necrosis factor-α and interleukin-1β gene expression following transient cerebral ischemia in miceNeuroscience Letters, 2002
- α‐MSH decreases apoptosis in ischaemic acute renal failure in rats: possible mechanism of this beneficial effectNephrology Dialysis Transplantation, 2001
- α-MSH Peptides Inhibit Production of Nitric Oxide and Tumor Necrosis Factor-α by Microglial Cells Activated with β-Amyloid and Interferon γBiochemical and Biophysical Research Communications, 1999
- Loss of Function Mutations of the Human Melanocortin 1 Receptor Are Common and Are Associated with Red HairBiochemical and Biophysical Research Communications, 1999
- Anti-inflammatory actions of the neuroimmunomodulator α-MSHImmunology Today, 1997
- Pharmacology of interleukin-1-induced neutrophil migrationInflammation Research, 1993